AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pirotis-MD 20 Tablet

Prescription Icon
Prescription Required

Marketer

Atlantis Formulations Pvt Ltd

Salt Composition

Piroxicam (20mg)

Overview Pirotis-MD 20 Tablet

Arthritis relief is provided by the 20mg Pirotis-MD tablet, effective for moderate to intense pain stemming from conditions like osteoarthritis and rheumatoid arthritis. It alleviates joint and muscle pain and inflammation. For optimal comfort, ingest Pirotis-MD 20mg with food to minimize stomach upset. Dosage and treatment length vary depending on individual response and condition. Continue using the medication as prescribed, even with symptom improvement, until your physician advises otherwise. Common side effects include mild nausea, vomiting, stomach discomfort, headache, and dizziness. Report any persistent or worsening side effects to your doctor, who can offer management strategies. Prior to use, disclose any history of stomach ulcers, heart conditions, hypertension, or liver/kidney impairment. Inform your doctor of all other medications you are currently taking, as interactions are possible. Pregnant or breastfeeding individuals should seek medical counsel before use.

Uses of Pirotis-MD 20 Tablet

Analgesia

Major Benefits of Pirotis-MD 20 Tablet:

Administer this medication precisely as your physician directs, adhering to both dosage and treatment length. Avoid contact with the tablets using damp hands. Place the tablet in your mouth; however, refrain from swallowing immediately. Consume Pirotis-MD 20 Tablet with a meal.

Common Side effects of Pirotis-MD 20 Tablet:

  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Pirotis-MD 20 Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Avoid handling the tablets with damp hands. Allow the Pirotis-MD 20 Tablet to dissolve in your mouth; do not ingest it whole. Administer this medication with a meal.

How Pirotis-MD 20 Tablet works:

Pirotis-MD 20 Tablet, a non-steroidal anti-inflammatory drug, inhibits the production of inflammatory mediators, thus alleviating pain and reducing swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Pirotis-MD 20 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Pirotis-MD 20 Tablet during pregnancy is contraindicated due to established risks to the fetus. Exceptions may be made by a physician in critical circumstances where potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Pirotis-MD 20 Tablet use are likely incompatible. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Pirotis-MD 20 Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Pirotis-MD 20 Tablet, as dose modification may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Pirotis-MD 20 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Pirotis-MD 20 Tablet :

Should you forget to take a Pirotis-MD 20 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Pirotis-MD 20 Tablet

LabelValue
Type of Compound Enolates and their related compounds
Addictive None.
Type of Medication Medications for Pain Relief

FAQs on Pirotis-MD 20 Tablet

Pirotis-MD 20 Tablet and diclofenac are both analgesics. Unlike diclofenac, which exhibits some selectivity for the COX-2 enzyme, piroxicam is a non-selective inhibitor of cyclooxygenase, an enzyme crucial in inflammatory processes and pain generation. This difference in COX enzyme selectivity suggests that diclofenac may produce fewer adverse effects than Pirotis-MD 20 Tablet.
Naproxen and Pirotis-MD 20 Tablet are comparable analgesic medications, both non-selectively inhibiting cyclooxygenase, the enzyme underlying inflammation and pain. Clinical trials indicate equivalent efficacy for both drugs. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse events compared to Pirotis-MD 20 Tablet.
Pirotis-MD 20 Tablet and meloxicam are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam exhibits a lower incidence of acute gastrointestinal adverse events than Pirotis-MD 20 Tablet.
Pirotis-MD 20 Tablet and ketoprofen are both nonsteroidal anti-inflammatory drugs (NSAIDs) used for pain relief, acting by inhibiting cyclooxygenase (COX), an enzyme involved in inflammation and pain signaling. Clinical trials indicate superior efficacy and tolerability of topical ketoprofen gel compared to Pirotis-MD 20 Tablet.
Pirotis-MD 20 Tablet targets COX, the enzyme mediating inflammation and pain, while Tramadol acts as an opioid analgesic. Tramadol carries a risk of dependence.
Pirotis-MD 20 Tablet and nimesulide are both analgesics. Pirotis-MD 20 Tablet, however, is a non-selective cyclooxygenase (COX) inhibitor, while nimesulide selectively targets COX-2. This selectivity in nimesulide is believed to reduce adverse reactions relative to piroxicam. Its use is contraindicated in children younger than 12 years.
Chikungunya typically doesn't cause a decrease in platelet levels. However, analgesics such as piroxicam increase the risk of bleeding. Therefore, avoid taking Pirotis-MD 20 Tablet or similar pain relievers if you experience fever and joint pain. Seek medical advice before commencing Pirotis-MD 20 Tablet treatment.
Pirotis-MD 20 Tablet and aspirin are distinct medications, despite both being classified as COX (cyclooxygenase) inhibitors. Both drugs share anti-inflammatory and analgesic properties.
Concurrent use of Pirotis-MD 20 Tablet and dexamethasone is contraindicated due to their potential for synergistic toxicity, significantly raising the likelihood of gastrointestinal ulceration.
Concurrent use of methocarbamol and Pirotis-MD 20 Tablet is considered safe, lacking documented severe adverse interactions. However, physician consultation is advised prior to initiating either treatment.
Affirmative. Concurrent use of paracetamol and Pirotis-MD 20 Tablet is considered safe, lacking documented significant adverse interactions. Physician consultation is advised prior to commencing either treatment.
Pirotis-MD 20 Tablet is classified as a nonsteroidal anti-inflammatory medication.
The medication Pirotis-MD 20 Tablet contains sulfur. This medication may trigger serious side effects in susceptible patients, including severe dermatological reactions such as Stevens-Johnson syndrome. Always disclose any allergies to your physician.
Pirotis-MD 20 Tablet does not prevent blood clots; it is an analgesic. Patients with bleeding disorders should not use this medication.
Pirotis-MD 20 Tablet does not relax muscles. It's an analgesic that targets COX enzymes (cyclooxygenase), which mediate inflammation and pain.
Pirotis-MD 20 Tablet is a non-narcotic analgesic. Its mechanism of action involves inhibiting COX enzymes, thereby reducing pain and inflammation.
Pirotis-MD 20 Tablet is unsuitable for managing high blood pressure. Concomitant use with antihypertensive drugs reduces their efficacy. Disclose current antihypertensive medication use to your physician prior to commencing Pirotis-MD 20 Tablet therapy.
Concomitant use of Pirotis-MD 20 Tablet and Losartan is contraindicated. Pirotis-MD 20 Tablet diminishes the efficacy of antihypertensive agents such as Losartan, potentially resulting in treatment failure. Disclose your current use of antihypertensive drugs to your physician prior to initiating Pirotis-MD 20 Tablet therapy.
Concurrent use of Pirotis-MD 20 Tablet and lisinopril is contraindicated. Piroxicam, the active ingredient in Pirotis-MD 20 Tablet, diminishes the efficacy of antihypertensive drugs such as lisinopril, potentially compromising blood pressure control. Disclose any current antihypertensive medication use to your physician prior to commencing Pirotis-MD 20 Tablet therapy.
Pirotis-MD 20 Tablet can be used concurrently with calcium channel blockers. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) may diminish the efficacy of most antihypertensive medications, calcium channel blockers being an exception (White, 2007).
Pirotis-MD 20 Tablet, containing piroxicam (an analgesic), can be used concurrently with tizanidine, a skeletal muscle relaxant. This combination is appropriate for conditions such as back pain.
Indeed, Pirotis-MD 20 Tablets are compatible with beta-cyclodextrin. Studies indicate this combination accelerates piroxicam's therapeutic effect and diminishes gastrointestinal adverse reactions.
Indeed, viable alternatives to Pirotis-MD 20 Tablet exist. Analgesic selection depends on the specific ailment. Physician consultation is necessary before initiating piroxicam therapy or switching medications.
Piroxicam should not be used in patients with allergies to the drug, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores (stomatitis), systemic lupus erythematosus (SLE), ulcerative colitis, upper gastrointestinal problems, late-stage pregnancy, heart conditions, liver dysfunction, or kidney impairment.
Pirotis-MD 20 Tablet does not alleviate allergic reactions; it is an analgesic.
Piroxicam 20 mg tablets, sold under the brand name Pirotis-MD, provide extended pain relief with a single daily dose. However, individual responses vary, and the analgesic effect of piroxicam typically improves with continued use over several weeks.
Pirotis-MD 20 Tablet does not have a known association with hypertension. This medication is a non-opioid analgesic.
The medication Pirotis-MD 20 Tablet lacks regulatory approval for managing dysmenorrhea. However, investigations indicate piroxicam's considerable efficacy in substantially reducing menstrual pain.
The medication Pirotis-MD 20 Tablet lacks regulatory approval for migraine treatment. However, clinical trials indicate its efficacy in substantially reducing migraine pain in patients without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's evaluation to determine the underlying cause of your back pain is necessary before commencing treatment. Avoid self-treating with Pirotis-MD 20 Tablet, as the etiology of back pain varies individually.
Indeed, Pirotis-MD 20 Tablets are indicated for acute gout management. Clinical trials demonstrate their significant efficacy in this context.
Blood donation is permissible while taking Pirotis-MD 20 Tablet; however, pre-donation physician consultation is recommended.
In diabetic patients, Pirotis-MD 20 tablets should be used only under a physician's supervision. Prolonged use of this medication carries a significant risk of kidney damage. Since diabetes itself increases the risk of kidney disease, adding piroxicam elevates this risk considerably.
Individuals with impaired kidney function should avoid Pirotis-MD 20 Tablet. Prolonged use of NSAIDs has been linked to kidney damage, including papillary necrosis.
Skin reactions, potentially severe and even life-threatening, are a known side effect of Pirotis-MD 20 Tablet. These reactions, including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), can develop unexpectedly. Discontinue use and consult your physician immediately if you experience any skin rash, even if mild.
Pirotis-MD 20 Tablet is contraindicated during pregnancy. Its use may result in premature ductus arteriosus closure, potentially causing fetal heart failure and mortality.
Pirotis-MD 20 Tablet is not suitable for patients with active peptic ulcers. This medication has been associated with the development of gastric ulcers and hemorrhage.
Individuals with asthma may experience heightened sensitivity to nonsteroidal anti-inflammatory medications (NSAIDs), such as aspirin, potentially triggering severe asthma episodes. Seek medical advice prior to commencing treatment with such drugs.
Affirmative. Pirotis-MD 20 Tablet may induce temporary infertility in some individuals. Piroxicam's mode of action can potentially impede or postpone follicular rupture in the ovaries, a phenomenon linked to reversible infertility. Physician consultation is advised prior to commencing treatment.
Concurrent administration of Pirotis-MD 20 Tablet and diuretics is contraindicated. In certain individuals, Pirotis-MD 20 Tablet diminishes the sodium-excreting action of furosemide and thiazide diuretics. This effect is believed to result from the suppression of renal prostaglandin production.
Concurrent use of Pirotis-MD 20 Tablet and lithium is contraindicated. Pirotis-MD 20 Tablet increases lithium plasma concentrations and decreases renal lithium excretion. This effect stems from the NSAID's inhibition of renal prostaglandin production. Physician consultation is mandatory prior to initiating Pirotis-MD 20 Tablet therapy.
Concurrent use of Pirotis-MD 20 Tablet and warfarin is contraindicated due to a heightened risk of hemorrhage. Patients should disclose all medications to their physician. If co-administered, rigorous monitoring of treatment is essential.
Individuals using corticosteroids and anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, tobacco use, and advanced age are additional risk factors for ulcer formation.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics, either immediately preceding or following coronary artery bypass grafting.
Gastrointestinal distress, and in uncommon instances, severe gastrointestinal adverse reactions including peptic ulcers and hemorrhage; severe cutaneous reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis; hepatic failure; and kidney injury.
Pirotis-MD 20 Tablet
39
MRP 48
18% off